← The Wire
GENBNasdaq
Generate Biomedicines, Inc.
Pharmaceutical Preparations · DE · CIK 2100782
Generate Biomedicines uses AI to program novel protein therapeutics for drug discovery and development
⚡ Elevated coverage
$1.59B
Market cap
$16.91
Last close
+2.7%
1D
+6.4%
5D
1.7M
Volume
Price · last 39 sessions+16.9%
May 4L $11.97 · H $16.91Jun 29
7
Total filings
May 7, 2026
Last filing
12/31
Fiscal year end
10-Q10-QMay 7, 20268-KResults of OperationsMay 7, 20268-KBylaw AmendmentMar 2, 2026424B4424B4Feb 27, 2026S-1/AS-1/AFeb 23, 2026S-1/AS-1/AFeb 13, 2026S-1S-1Feb 4, 2026
Insider Activity
◆ Cluster Buy · 6 insidersIn the 90 days to Mar 4, 2026: 6 insiders bought $50.3M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 4, 2026 | Nally MichaelChief Executive Officer | Buy | 20,000 | $12.00 | $240K |
| Mar 2, 2026 | Flagship Pioneering Fund Vi, L.P.TenPercentOwner | Buy | 1,562,500 | $16.00 | $25.0M |
| Mar 2, 2026 | Nutritional Health Ltp Fund General Partner LlcTenPercentOwner | Buy | 1,562,500 | $16.00 | $25.0M |
| Mar 2, 2026 | Mendillo Jane LDirector | Buy | 1,500 | $16.00 | $24K |
| Mar 2, 2026 | Silvers JasonPresident & CFO | Buy | 1,000 | $16.00 | $16K |
| Mar 2, 2026 | Silvers JasonPresident & CFO | Buy | 500 | $16.00 | $8K |
| Mar 2, 2026 | Grous BethChief People Officer | Buy | 300 | $16.00 | $5K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
⚡ Elevated coverageCoverage (30d): 1 reputable article.
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance